Skip to main content

Want a detailed portfolio tracker?

Dyadic International Inc DE (DYAI) P/E (2018 - 2026)

Dyadic International Inc DE (DYAI) P/E from Dec 31, 2018 to Jul 21, 2026. The TTM Dyadic International Inc DE (DYAI) P/E is -6.97. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Dyadic International Inc DE (DYAI)

YearP/EChange
2026-6.97+67.06%
2025-4.17-53.03%
2024-8.88+31.84%
2023-6.73+71.10%
2022-3.94-72.14%
2021-14.13-10.94%
2020-15.86-5.90%
2019-16.86-82.97%
2018-99.00N/A

Comparison Dyadic International Inc DE (DYAI) P/E with competitors

Dyadic International Inc DE (DYAI) P/E is -6.97.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.07%
FGENFibroGen Inc0.24-103.45%
CHRSCoherus Biosciences Inc0.85-112.18%
FBIOFortress Biotech Inc0.95-113.62%
ORMPOramed Pharmaceuticals Inc1.50-121.57%
AGENAgenus Inc3.01-143.20%
INVAInnoviva Inc3.15-145.27%
VXRTVaxart Inc3.55-150.95%
CRMDCorMedix Inc3.63-152.08%
CVACCureVac N.V.4.45-163.81%
GLPGGalapagos NV4.86-169.74%
SRPTSarepta Therapeutics Inc4.88-170.08%
ABEOAbeona Therapeutics Inc5.39-177.33%
ABUSArbutus Biopharma Corp5.60-180.32%
ZVRAZevra Therapeutics Inc5.89-184.51%
SPROSpero Therapeutics Inc6.23-189.40%
CGENCompugen Ltd6.31-190.63%
RIGLRigel Pharmaceuticals6.87-198.64%
SLXNSilexion Therapeutics Corp7.30-204.73%
OMEROmeros Corporation9.26-232.90%
AUPHAurinia Pharmaceuticals Inc9.58-237.58%
PLXProtalix BioTherapeutics Inc10.89-256.33%
ACADAcadia Pharmaceuticals Inc11.73-268.35%
TBPHTheravance Biopharma Inc12.26-276.01%
ADMAAdma Biologics Inc12.42-278.25%
HRMYHarmony Biosciences Holdings Inc13.82-298.38%
SABSSAB Biotherapeutics Inc14.14-302.91%
NAGENiagen Bioscience Inc14.82-312.70%
INCYIncyte Corp15.82-327.12%
REGNRegeneron Pharmaceuticals Inc15.86-327.61%
PBYIPuma Biotechnology Inc17.32-348.55%
CPRXCatalyst Pharmaceuticals Inc17.44-350.32%
EXELExelixis Inc17.54-351.74%
TGTXTG Therapeutics Inc18.97-372.24%
MDXGMimedx Group Inc20.55-395.01%
XOMAXOMA Royalty Corp22.87-428.35%
ARGXArgen X SE24.30-448.78%
CTMXCytomX Therapeutics Inc24.82-456.29%
XOMAOXOMA Royalty Corp25.34-463.81%
HALOHalozyme Therapeutics Inc25.62-467.81%
XOMAPXOMA Royalty Corp25.67-468.48%
VRTXVertex Pharmaceuticals Inc27.99-501.85%
RPRXRoyalty Pharma plc - Class A28.69-511.79%
SLNOSoleno Therapeutics Inc29.02-516.50%
ASNDAscendis Pharma A/S30.09-531.86%
LGNDLigand Pharmaceuticals Inc - Class B37.91-644.20%
APLSApellis Pharmaceuticals Inc39.02-660.13%
BMRNBiomarin Pharmaceutical Inc42.21-705.93%
KRYSKrystal Biotech Inc45.34-750.88%
ONCBeiGene Ltd69.54-1098.21%
PHARPharming Group N.V.75.03-1176.95%
TECHBio-Techne Corp101.96-1563.55%
VCELVericel Corp109.92-1677.86%
ALNYAlnylam Pharmaceuticals Inc117.96-1793.32%
GMABGenmab140.29-2113.79%
TLXTelix Pharmaceuticals Ltd162.15-2427.61%
CORTCorcept Therapeutics Inc212.86-3155.45%